Pharmaceuticals-maker Sanofi-Synthelabo yesterday announced plans to create the world's third largest pharmaceutical company after making a new, "friendly" bid for the Franco-German Aventis SA worth 54.5 billion euros (US$64.31 billion).
The new offer has been approved by Sanofi's board, its main shareholders Total SA and L'Oreal SA as well as by Aventis' management and supervisory boards, a statement said.
PHOTO: AP
The offer that ends a three-month hostile takeover battle was made public on Sunday night by French authorities. The Sanofi statement yesterday provided more details.
The merger -- which must be approved by shareholders -- would create a new world No. 3 behind US giant Pfizer Inc and Britain's GlaxoSmithKline PLC.
Sanofi said the sweetened offer was filed yesterday in Paris, and will be filed in the US and Germany during the next few days.
The new company would be called Sanofi-Aventis.
Jean-Francois Dehecq, chairman and chief executive of Sanofi-Synthelabo, is to be chairman and chief executive officer of the new entity, the statement said. Sanofi-Aventis' board would be made up of 17 members, including Dehecq, eight members chosen by Aventis and eight members selected by Sanofi.
The new company would have an audit committee, a remuneration committee, a scientific committee and a strategic committee, Sanofi said. Aventis and Sanofi would have equal representation in each committee.
French authorities quickly welcomed the deal concluded on Sunday. Prime Minister Jean-Pierre Raffarin's government had sought to discourage Aventis' attempts to negotiate a friendly merger with Switzerland's Novartis AG. He said the Sanofi-Aventis deal was in France's "strategic interests" because it would "maintain decision-making centers and jobs in France and Europe."
Aventis had rejected Sanofi's hostile Jan 26 cash-and-share offer, worth 47.8 billion euros.
Novartis, which makes blood pressure treatment Diovan and anti-leukemia drug Gleevec, withdrew from the race, signaling unwillingness to be drawn into a bidding war for Aventis against its government-backed rival.
"Following Aventis' decision to engage in discussions with Sanofi, at the strong intervention of the French government, Novartis decided not to proceed," the company said in a statement, adding that it had made no formal offer and that its decision was final.
Only Thursday, Novartis had said it was entering merger talks with Aventis as a possible "white knight" bidder for the Strasbourg-based maker of anti-thrombosis drug Lovenox.
The following day, at the request of French Finance Minister Nicolas Sarkozy, Landau met Dehecq for their first direct talks in the three months since Sanofi launched its hostile bid.
A French government official, who asked not to be named, told reporters on Sunday that Finance Minister Nicolas Sarkozy had put heavy pressure on Dehecq to raise his offer for Aventis.
The French prime minister had said last month that a tie-up between Aventis and Sanofi was in the "national interest."
That position was reiterated by two government ministers on Sunday, even as Aventis directors were considering their company's future.
Health Minister Philippe Douste-Blazy said in a radio interview that a deal between the French-based companies would be "a very good thing" for the country's industry, while Industry Minister Patrick Devedjian told LCI television that the government remained "legally" neutral even though it openly supported the Sanofi bid.
"When you watch a football match, you can support one side or the other, but you're not the referee," Devedjian said.
The deal between Sanofi and Aventis ends three months of bitter verbal warfare between the two companies. Dehecq talked down Aventis' drug development pipeline, while Aventis filed lawsuits against Sanofi and warned investors that a US patent challenge to it's blockbuster blood thinner, Plavix, was a time bomb that could slash its share price.
The lawsuits will be dropped, the Sanofi statement said.
WAITING GAME: The US has so far only offered a ‘best rate tariff,’ which officials assume is about 15 percent, the same as Japan, a person familiar with the matter said Taiwan and the US have completed “technical consultations” regarding tariffs and a finalized rate is expected to be released soon, Executive Yuan spokeswoman Michelle Lee (李慧芝) told a news conference yesterday, as a 90-day pause on US President Donald Trump’s “reciprocal” tariffs is set to expire today. The two countries have reached a “certain degree of consensus” on issues such as tariffs, nontariff trade barriers, trade facilitation, supply chain resilience and economic security, Lee said. They also discussed opportunities for cooperation, investment and procurement, she said. A joint statement is still being negotiated and would be released once the US government has made
Authorities have detained three former Taiwan Semiconductor Manufacturing Co (TMSC, 台積電) employees on suspicion of compromising classified technology used in making 2-nanometer chips, the Taiwan High Prosecutors’ Office said yesterday. Prosecutors are holding a former TSMC engineer surnamed Chen (陳) and two recently sacked TSMC engineers, including one person surnamed Wu (吳) in detention with restricted communication, following an investigation launched on July 25, a statement said. The announcement came a day after Nikkei Asia reported on the technology theft in an exclusive story, saying TSMC had fired two workers for contravening data rules on advanced chipmaking technology. Two-nanometer wafers are the most
NEW GEAR: On top of the new Tien Kung IV air defense missiles, the military is expected to place orders for a new combat vehicle next year for delivery in 2028 Mass production of Tien Kung IV (Sky Bow IV) missiles is expected to start next year, with plans to order 122 pods, the Ministry of National Defense’s (MND) latest list of regulated military material showed. The document said that the armed forces would obtain 46 pods of the air defense missiles next year and 76 pods the year after that. The Tien Kung IV is designed to intercept cruise missiles and ballistic missiles to an altitude of 70km, compared with the 60km maximum altitude achieved by the Missile Segment Enhancement variant of PAC-3 systems. A defense source said yesterday that the number of
Taiwanese exports to the US are to be subject to a 20 percent tariff starting on Thursday next week, according to an executive order signed by US President Donald Trump yesterday. The 20 percent levy was the same as the tariffs imposed on Vietnam, Sri Lanka and Bangladesh by Trump. It was higher than the tariffs imposed on Japan, South Korea and the EU (15 percent), as well as those on the Philippines (19 percent). A Taiwan official with knowledge of the matter said it is a "phased" tariff rate, and negotiations would continue. "Once negotiations conclude, Taiwan will obtain a better
RSS